NCT07374614
- Conditions
- ALK, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
Clinical trial condition
ALK
Explore clinical trials studying ALK. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
ALK trial results
Not Yet Recruiting
Ensartinib After Chemoradiotherapy in Stage III ALK-Mutated NSCLC
NCT07235306
- Conditions
- ALK, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
Not specified
Not Yet Recruiting
The Efficacy and Safety of Ensartinib As Adjuvant Therapy in Stage I ALK-positive NSCLC Patients with High Risk Factors
NCT06772610
- Conditions
- ALK, Adjuvant Treatment, NSCLC, +1 more
- Locations
-
Not specified
Not Yet Recruiting
The Incidence and Risk Factors of Central Nervous System Adverse Events of Lorlatinib in Patients with ALK-positive Advanced Non-small Cell Lung Cancer: a Real-world Study
NCT06652555
- Conditions
- ALK, NSCLC
- Locations
-
Not specified